亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19

物理疗法 医学 慢性疼痛 心情 随机对照试验 剧痛 安慰剂 物理医学与康复 临床心理学 外科 病理 替代医学
作者
Laura Martínez García,Brandon Birckhead,Parthasarathy Krishnamurthy,Josh Sackman,Ian Mackey,Robert G. Louis,Vafi Salmasi,Todd Maddox,Beth D. Darnall
出处
期刊:Journal of Medical Internet Research [JMIR Publications]
卷期号:23 (2): e26292-e26292 被引量:82
标识
DOI:10.2196/26292
摘要

Background Chronic low back pain is the most prevalent chronic pain condition worldwide and access to behavioral pain treatment is limited. Virtual reality (VR) is an immersive technology that may provide effective behavioral therapeutics for chronic pain. Objective We aimed to conduct a double-blind, parallel-arm, single-cohort, remote, randomized placebo-controlled trial for a self-administered behavioral skills-based VR program in community-based individuals with self-reported chronic low back pain during the COVID-19 pandemic. Methods A national online convenience sample of individuals with self-reported nonmalignant low back pain with duration of 6 months or more and with average pain intensity of 4 or more/10 was enrolled and randomized 1:1 to 1 of 2 daily (56-day) VR programs: (1) EaseVRx (immersive pain relief skills VR program); or (2) Sham VR (2D nature content delivered in a VR headset). Objective device use data and self-reported data were collected. The primary outcomes were the between-group effect of EaseVRx versus Sham VR across time points, and the between–within interaction effect representing the change in average pain intensity and pain-related interference with activity, stress, mood, and sleep over time (baseline to end-of-treatment at day 56). Secondary outcomes were global impression of change and change in physical function, sleep disturbance, pain self-efficacy, pain catastrophizing, pain acceptance, pain medication use, and user satisfaction. Analytic methods included intention-to-treat and a mixed-model framework. Results The study sample was 179 adults (female: 76.5%, 137/179; Caucasian: 90.5%, 162/179; at least some college education: 91.1%, 163/179; mean age: 51.5 years [SD 13.1]; average pain intensity: 5/10 [SD 1.2]; back pain duration ≥5 years: 67%, 120/179). No group differences were found for any baseline variable or treatment engagement. User satisfaction ratings were higher for EaseVRx versus Sham VR (P<.001). For the between-groups factor, EaseVRx was superior to Sham VR for all primary outcomes (highest P value=.009), and between-groups Cohen d effect sizes ranged from 0.40 to 0.49, indicating superiority was moderately clinically meaningful. For EaseVRx, large pre–post effect sizes ranged from 1.17 to 1.3 and met moderate to substantial clinical importance for reduced pain intensity and pain-related interference with activity, mood, and stress. Between-group comparisons for Physical Function and Sleep Disturbance showed superiority for the EaseVRx group versus the Sham VR group (P=.022 and .013, respectively). Pain catastrophizing, pain self-efficacy, pain acceptance, prescription opioid use (morphine milligram equivalent) did not reach statistical significance for either group. Use of over-the-counter analgesic use was reduced for EaseVRx (P<.01) but not for Sham VR. Conclusions EaseVRx had high user satisfaction and superior and clinically meaningful symptom reduction for average pain intensity and pain-related interference with activity, mood, and stress compared to sham VR. Additional research is needed to determine durability of treatment effects and to characterize mechanisms of treatment effects. Home-based VR may expand access to effective and on-demand nonpharmacologic treatment for chronic low back pain. Trial Registration ClinicalTrials.gov NCT04415177; https://clinicaltrials.gov/ct2/show/NCT04415177 International Registered Report Identifier (IRRID) RR2-10.2196/25291

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
实验大牛完成签到,获得积分10
1秒前
852应助scholar丨崔采纳,获得10
14秒前
15秒前
一D完成签到,获得积分10
18秒前
儒雅致远发布了新的文献求助10
21秒前
YiPeng完成签到,获得积分10
22秒前
25秒前
核桃发布了新的文献求助10
30秒前
桐桐应助儒雅致远采纳,获得10
31秒前
核桃完成签到,获得积分0
35秒前
排骨大王完成签到,获得积分10
36秒前
37秒前
joker完成签到 ,获得积分10
41秒前
核桃发布了新的文献求助100
44秒前
48秒前
温暖元容完成签到,获得积分10
51秒前
scholar丨崔发布了新的文献求助10
55秒前
1分钟前
淡定的彩虹完成签到,获得积分10
1分钟前
1分钟前
sss发布了新的文献求助10
1分钟前
1分钟前
情怀应助科研通管家采纳,获得10
1分钟前
1分钟前
卡卡完成签到 ,获得积分10
1分钟前
CNY完成签到 ,获得积分10
1分钟前
赘婿应助_ban采纳,获得10
1分钟前
2分钟前
bksqc发布了新的文献求助10
2分钟前
bksqc完成签到,获得积分10
2分钟前
卑微学术人完成签到 ,获得积分10
2分钟前
2分钟前
无花果应助feifei采纳,获得10
2分钟前
griffon完成签到,获得积分10
3分钟前
汉堡包应助通通采纳,获得10
3分钟前
3分钟前
Huay完成签到 ,获得积分10
3分钟前
tingting9发布了新的文献求助10
3分钟前
英俊的铭应助科研通管家采纳,获得10
3分钟前
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990020
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256276
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228